NRG4
Summary: The neuregulins, including NRG4, activate type-1 growth factor receptors (see EGFR; MIM 131550) to initiating cell-to-cell signaling through tyrosine phosphorylation (Harari et al., 1999 [PubMed 10348342]).[supplied by OMIM, Mar 2008].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
neuregulin 4 | MIM:610894 | Ensembl:ENSG00000169752 | HGNC:HGNC:29862 | PA142671246 | 15q24.2 |
GO terms in NRG4
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
CC | TAS | GO:0005576 | extracellular region |
CC | IBA | GO:0005615 | extracellular space |
CC | IEA | GO:0005622 | intracellular |
CC | IEA | GO:0005886 | plasma membrane |
CC | IEA | GO:0016021 | integral component of membrane |
BP | TAS | GO:0000165 | MAPK cascade |
BP | IEA | GO:0010469 | regulation of signaling receptor activity |
BP | IEA | GO:0018108 | peptidyl-tyrosine phosphorylation |
BP | IBA | GO:0035556 | intracellular signal transduction |
BP | TAS | GO:0038128 | ERBB2 signaling pathway |
BP | IEA | GO:0046854 | phosphatidylinositol phosphorylation |
BP | IBA | GO:0048513 | animal organ development |
BP | TAS | GO:0051897 | positive regulation of protein kinase B signaling |
BP | TAS | GO:2000145 | regulation of cell motility |
MF | TAS | GO:0004713 | protein tyrosine kinase activity |
MF | TAS | GO:0005088 | Ras guanyl-nucleotide exchange factor activity |
MF | IBA | GO:0005102 | signaling receptor binding |
MF | IPI | GO:0005515 | protein binding |
MF | IEA | GO:0008083 | growth factor activity |
MF | TAS | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity |
Gene expression in normal tissue: NRG4
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in NRG4
Database | Pathway ID | Pathway Des. |
---|---|---|
biocarta | erbb4pathway | g-secretase mediated erbb4 signaling pathway |
reactome | R-HSA-1227986 | Signaling by ERBB2 |
reactome | R-HSA-1227986 | Signaling by ERBB2 |
reactome | R-HSA-1236394 | Signaling by ERBB4 |
reactome | R-HSA-1236394 | Signaling by ERBB4 |
reactome | R-HSA-1250196 | SHC1 events in ERBB2 signaling |
reactome | R-HSA-1250196 | SHC1 events in ERBB2 signaling |
reactome | R-HSA-1250342 | PI3K events in ERBB4 signaling |
reactome | R-HSA-1250347 | SHC1 events in ERBB4 signaling |
reactome | R-HSA-1251985 | Nuclear signaling by ERBB4 |
reactome | R-HSA-1257604 | PIP3 activates AKT signaling |
reactome | R-HSA-162582 | Signal Transduction |
reactome | R-HSA-162582 | Signal Transduction |
reactome | R-HSA-1643685 | Disease |
reactome | R-HSA-1963640 | GRB2 events in ERBB2 signaling |
reactome | R-HSA-1963642 | PI3K events in ERBB2 signaling |
reactome | R-HSA-199418 | Negative regulation of the PI3K/AKT network |
reactome | R-HSA-2219528 | PI3K/AKT Signaling in Cancer |
reactome | R-HSA-2219530 | Constitutive Signaling by Aberrant PI3K in Cancer |
reactome | R-HSA-5663202 | Diseases of signal transduction |
reactome | R-HSA-5673001 | RAF/MAP kinase cascade |
reactome | R-HSA-5683057 | MAPK family signaling cascades |
reactome | R-HSA-5684996 | MAPK1/MAPK3 signaling |
reactome | R-HSA-6785631 | ERBB2 Regulates Cell Motility |
reactome | R-HSA-6811558 | PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling |
reactome | R-HSA-8847993 | ERBB2 Activates PTK6 Signaling |
reactome | R-HSA-8848021 | Signaling by PTK6 |
reactome | R-HSA-8863795 | Downregulation of ERBB2 signaling |
reactome | R-HSA-9006925 | Intracellular signaling by second messengers |
reactome | R-HSA-9006927 | Signaling by Non-Receptor Tyrosine Kinases |
reactome | R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases |
reactome | R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases |
wikipathways | WP673 | ErbB Signaling Pathway |
pid | erbb_network_pathway | ErbB receptor signaling network |
kegg | hsa04012 | ErbB signaling pathway - Homo sapiens (human) |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in NRG4